Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac in cataract surgery
NCT00853970Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Feb 2009
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bromfenac sodium in post-operative ocular inflammation, post-operative ocular pain, sponsored by Bausch + Lomb. Started Feb 2009; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
post-operative ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on NCT00853970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853970.